Line 1: |
Line 1: |
− | ==Forewords and Introductions[[Forewords and Introductions|Overview Page Link]]== | + | ==Forewords and Introductions ([[Forewords and Introductions|Overview Page Link]])== |
− | ==Myeloid proliferations and neoplasms[[Myeloid proliferations and neoplasms|Overview Page Link]]== | + | ==Myeloid proliferations and neoplasms ([[Myeloid proliferations and neoplasms|Overview Page Link]])== |
| ===Myeloid precursor lesions=== | | ===Myeloid precursor lesions=== |
| ''Clonal Haematopoiesis'' | | ''Clonal Haematopoiesis'' |
Line 87: |
Line 87: |
| - [[Acute leukaemia of ambiguous lineage, NOS]] | | - [[Acute leukaemia of ambiguous lineage, NOS]] |
| - [[Acute undifferentiated leukaemia]] | | - [[Acute undifferentiated leukaemia]] |
− | ==Histiocytic/Dendritic cell neoplasms[[Histiocytic/Dendritic cell neoplasms|Overview Page Link]]== | + | ==Histiocytic/Dendritic cell neoplasms ([[Histiocytic/Dendritic cell neoplasms|Overview Page Link]])== |
| ===Plasmacytoid dendritic cell neoplasms=== | | ===Plasmacytoid dendritic cell neoplasms=== |
| ''Plasmacytoid dendritic cell neoplasms'' | | ''Plasmacytoid dendritic cell neoplasms'' |
Line 106: |
Line 106: |
| - [[ALK-positive histiocytosis]] | | - [[ALK-positive histiocytosis]] |
| - [[Histiocytic sarcoma]] | | - [[Histiocytic sarcoma]] |
− | ==B-cell lymphoid proliferations and lymphomas[[B-cell lymphoid proliferations and lymphomas|Overview Page Link]]== | + | ==B-cell lymphoid proliferations and lymphomas ([[B-cell lymphoid proliferations and lymphomas|Overview Page Link]])== |
| ===Tumour like lesions with B-cell predominance=== | | ===Tumour like lesions with B-cell predominance=== |
| - [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] | | - [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] |
Line 209: |
Line 209: |
| - [[Plasma cell myeloma / multiple myeloma]] | | - [[Plasma cell myeloma / multiple myeloma]] |
| - [[Plasma cell neoplasms with associated paraneoplastic syndrome]] | | - [[Plasma cell neoplasms with associated paraneoplastic syndrome]] |
− | ==T-cell and NK-cell lymphoid proliferations and lymphomas [[T-cell and NK-cell lymphoid proliferations and lymphomas |Overview Page Link]]== | + | ==T-cell and NK-cell lymphoid proliferations and lymphomas ([[T-cell and NK-cell lymphoid proliferations and lymphomas |Overview Page Link]])== |
| ===Tumour-like lesions with T-cell predominance=== | | ===Tumour-like lesions with T-cell predominance=== |
| - [[Kikuchi-Fujimoto disease]] | | - [[Kikuchi-Fujimoto disease]] |
Line 262: |
Line 262: |
| - [[Systemic chronic active EBV disease]] | | - [[Systemic chronic active EBV disease]] |
| - [[Systemic EBV-positive T-cell lymphoma of childhood]] | | - [[Systemic EBV-positive T-cell lymphoma of childhood]] |
− | ==Stroma-derived neoplasms of lymphoid tissues[[Stroma-derived neoplasms of lymphoid tissues|Overview Page Link]]== | + | ==Stroma-derived neoplasms of lymphoid tissues ([[Stroma-derived neoplasms of lymphoid tissues|Overview Page Link]])== |
| ===Mesenchymal dendritic cell neoplasms=== | | ===Mesenchymal dendritic cell neoplasms=== |
| ''Follicular dendritic cell neoplasms'' | | ''Follicular dendritic cell neoplasms'' |
Line 276: |
Line 276: |
| - [[Splenic hamartoma]] | | - [[Splenic hamartoma]] |
| - [[Sclerosing angiomatoid nodular transformation (SANT) of spleen]] | | - [[Sclerosing angiomatoid nodular transformation (SANT) of spleen]] |
− | ==Genetic tumour syndromes[[Genetic tumour syndromes|Overview Page Link]]== | + | ==Genetic tumour syndromes ([[Genetic tumour syndromes|Overview Page Link]])== |
| - [[Fanconi anaemia]] | | - [[Fanconi anaemia]] |
| - [[Bloom syndrome]] | | - [[Bloom syndrome]] |
| - [[Ataxia-telangiectasia syndrome]] | | - [[Ataxia-telangiectasia syndrome]] |
− | - [[RASopathies]] | + | - [[RASopathies] |